Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
Purdue Pharma sentenced to $5.5 billion for opioid crisis, enabling $7.4 billion settlement.Summary
Purdue Pharma was sentenced to a $5.5 billion fine for its role in the opioid epidemic, which will facilitate a $7.4 billion settlement to compensate victims. The sentencing in New Jersey federal court allows the company to dissolve in bankruptcy and allocate assets to the settlement. The process involved extensive victim testimonies, with the judge emphasizing the need for accountability. However, many victims expressed frustration over the settlement's limitations, as it may exclude those unable to provide historical prescription records. Purdue Pharma will cease operations by May 1, transitioning to a nonprofit focused on addiction treatment. The company admitted to paying kickbacks to doctors and misleading regulators about OxyContin's risks. The settlement, while hailed as a victory, faces challenges in accessibility for affected individuals.
(Source：Cnbc)